CDSS Market

Global CDSS Market Size (2024 to 2032)

The size of the global clinical decision support systems market was worth USD 1,126 million in 2023. The global market is anticipated to grow at a CAGR of 11.8% from 2024 to 2032 and be worth USD 3,073 million by 2032 from USD 1,259 million in 2024. 

MARKET SCENARIO

The market is experiencing relatively more significant growth in health, IT budgets, and health markets. The clinical decision-making system worldwide is increasing with the care rule, and the increase in primary health care will likely boost market growth.

Clinical decision support is a clinical and practical tool that helps improve the operational efficiency of health practices. Hospitals and clinics must deal with enormous clinical and clinical information. To handle the large volume of data, medical professionals and reception staff are always looking for an efficient way to record, store, and improve access to patient information.

The United States Food and Drug Administration (FDA) has announced regulatory approval for the Viz.AI application, the first clinical decision support (CDS) based on artificial intelligence. Of the world, which was approved for sale in the United States. Viz.AI Contact is used to analyze the results of computed tomography (CT).

Clinical decision support is a clinical and practical tool that helps improve the operational efficiency of health practices. Hospitals and clinics must deal with enormous clinical and clinical information. To handle the large volume of data, medical professionals and reception staff are always looking for an efficient way to record, store, and improve access to patient information—the support system for the clinical decision and the patient's clinical workflow. The physics recommendations for systems and systems can also accelerate the market growth of clinical decision support systems. These factors are projected soon to boost the demand for a clinical decision support system. Also, advances in the development of a system to support clinical decisions.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global CDSS Market Analysis By Component

• Hardware
• Software
• Services

Global CDSS Market Analysis By Delivery Mode

• Cloud-based
• On-premise

Global CDSS Market Analysis By Product

• Standalone CDSS
• Integrated CDSS

Global CDSS Market Analysis By Type

• Therapeutic CDSS
• Diagnostic CDSS

Global CDSS Market Analysis By Model

• Knowledge-based CDSS
• Non-Knowledge-based CDSS

Global CDSS Market Analysis By User Interactivity

• Active CDSS
• Passive CDSS

Global CDSS Market Analysis By Application

• Conventional CDSS
• Advanced CDSS

Global CDSS Market Analysis By Setting

• Inpatient Settings
• Ambulatory Care Settings

REGIONAL ANALYSIS

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

North America dominated the CDSS market and is expected to continue dominating throughout the forecast period. The growth of the North American market is primarily driven by factors such as technologically advanced research and diagnostic treatment platforms for chronic diseases, the presence of many reimbursement policies, the strengthening of health infrastructure in Canada, and the development of IT health organizations in North America. Besides, the number of GP surgeries in the United States has increased, which should help drive the expansion of the US cloud-based clinical decision support system over the forecast period.  The U.S. CDSS market accounted for the dominating share of the North American region in 2023, followed by Canada.

The European CDSS market is estimated to grow at a healthy CAGR in the coming years and hold decent occupancy in the global market during the forecast period.

The APAC CDSS market is expected to be the fastest-growing region for clinical decision support systems over the forecast period. On the other hand, in the Asia-Pacific region, China dominated the market for clinical decision support systems, while India is expected to grow exponentially over the forecast period.

The CDSS market in Latin America is predicted to grow steadily during the forecast period.

The MEA CDSS market is projected to hold a moderate share of the worldwide market in the coming years.

KEY PLAYERS IN THE GLOBAL CDSS MARKET

Wolters Kluwer Health (USA), Hearst Health (USA), and Elsevier B.V. (Netherlands) are the leading players in the market. Other key players include Cerner Corporation (USA), McKesson Corporation (USA), Epic Systems Corporation (USA), MEDITECH (USA), Philips Healthcare (Netherlands) and International Business Machines (IBM) (USA), and Allscripts Healthcare Solutions, Inc. (USA).